1. Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. Issue 4 (April 2021) Authors: Lee, Nancy Y; Ferris, Robert L; Psyrri, Amanda; Haddad, Robert I; Tahara, Makoto; Bourhis, Jean; Harrington, Kevin; Chang, Peter Mu-Hsin; Lin, Jin-Ching; Razaq, Mohammad Abdul; Teixeira, Maria Margarida; Lövey, József; Chamois, Jerome; Rueda, Antonio; Hu, Chaosu; Dunn, Lara A; Dvorkin, Mikhail Vl... Journal: Lancet oncology Issue: Volume 22:Issue 4(2021) Page Start: 450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cisplatin-Based Chemotherapy versus Cetuximab in Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer Treatment. (6th July 2014) Authors: Hu, Ming-Hung; Wang, Ling-Wei; Lu, Hsueh-Ju; Chu, Pen-Yuan; Tai, Shyh-Kuan; Lee, Tsung-Lun; Chen, Ming-Huang; Yang, Muh-Hwa; Chang, Peter Mu-Hsin Other Names: Yen Yun Academic Editor. Journal: BioMed research international Issue: Volume 2014(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/II Clinical Study. (18th April 2016) Authors: Chen, San-Chi; Chang, Peter Mu-Hsin; Yang, Muh-Hwa Journal: Oncologist Issue: Volume 21:Number 5(2016) Page Start: 537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Combination of pembrolizumab and lenvatinib is a potential treatment option for heavily pretreated recurrent and metastatic head and neck cancer. Issue 4 (31st March 2021) Authors: Chen, Tien-Hua; Chang, Peter Mu-Hsin; Yang, Muh-Hwa Journal: Journal of the Chinese Medical Association Issue: Volume 84:Issue 4(2021) Page Start: 361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer. (18th August 2014) Authors: Huang, Chien-Hung; Chang, Peter Mu-Hsin; Lin, Yong-Jie; Wang, Cheng-Hsu; Huang, Chi-Ying F.; Ng, Ka-Lok Other Names: Li X. Academic Editor. Journal: BioMed research international Issue: Volume 2014(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of cetuximab-containing regimens in the treatment of recurrent/metastatic head and neck cancer after progression to immune checkpoint inhibitors. Issue 6 (10th June 2022) Authors: Lai, Cheng-Lun; Chen, Tien-Hua; Chang, Peter Mu-Hsin; Tai, Shyh-Kuan; Chu, Pen-Yuan; Yang, Muh-Hwa Journal: Journal of the Chinese Medical Association Issue: Volume 85:Issue 6(2022) Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Modified Sijunzi decoction can alleviate cisplatin-induced toxicity and prolong the survival time of cachectic mice by recovering muscle atrophy. (6th April 2019) Authors: Chen, Jing-Ming; Yang, Ting-Ting; Cheng, Tai-Shan; Hsiao, Ting-Fen; Chang, Peter Mu-Hsin; Leu, Jyh-Yih; Wang, Feng-Sheng; Hsu, Shih-Lan; Huang, Chi-Ying F.; Lai, Jin-Mei Journal: Journal of ethnopharmacology Issue: Volume 233(2019) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer. (17th November 2014) Authors: Lu, Hsueh-Ju; Yang, Chao-Chun; Wang, Ling-Wei; Chu, Pen-Yuan; Tai, Shyh-Kuan; Chen, Ming-Huang; Yang, Muh-Hwa; Chang, Peter Mu-Hsin Other Names: Yen Yun Academic Editor. Journal: BioMed research international Issue: Volume 2015(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Oncogene inference optimization using constraint-based modelling incorporated with protein expression in normal and tumour tissues. Issue 3 (18th March 2020) Authors: Wu, Wu-Hsiung; Li, Fan-Yu; Shu, Yi-Chen; Lai, Jin-Mei; Chang, Peter Mu-Hsin; Huang, Chi-Ying F.; Wang, Feng-Sheng Journal: Royal Society open science Issue: Volume 7:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population. Issue 52 (December 2017) Authors: Chen, Wen-Chun; Chu, Pen-Yuan; Lee, Yu-Ting; Lu, Wen-Bin; Liu, Chun-Yu; Chang, Peter Mu-Hsin; Yang, Muh-Hwa Other Names: Thakkar. Prashant section editor. Journal: Medicine Issue: Volume 96:Issue 52(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗